| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
37,720,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Bicycle Therapeutics is a holding company. Through its subsidiaries, Co. is a clinical-stage biopharmaceutical company developing a class of medicines, which it refers to as Bicycles. Bicycles are a therapeutic modality combining the pharmacology associated with a biologic with the manufacturing and pharmacokinetic properties of a small molecule. Co. is evaluating BT5528, a Bicycle Toxin Conjugate (BTC) targeting Ephrin type-A receptor 2, BT8009, a BTC™ targeting Nectin-4, and BT7480, a Bicycle tumor-targeted immune cell agonist® targeting Nectin-4 and agonizing CD137. In addition, BT1718, a BTC that is being developed to target tumors that express Membrane Type 1 matrix metalloproteinase.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
7,222 |
27,098 |
33,468 |
53,826 |
| Total Sell Value |
$171,618 |
$519,450 |
$663,415 |
$1,227,017 |
| Total People Sold |
7 |
7 |
7 |
9 |
| Total Sell Transactions |
7 |
13 |
25 |
38 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Baker Julian |
|
– • • |
2024-04-18 |
4 |
A |
$0.00 |
$0 |
I/I |
24,000 |
6,449,320 |
|
- |
|
| Baker Julian |
|
– • • |
2024-04-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,017,176 |
|
- |
|
| Hannay Michael Charles Ferguson |
CHIEF PROD & SUPPLY CHAIN OFF |
• – – |
2024-04-11 |
4 |
S |
$22.49 |
$5,780 |
D/D |
(257) |
22,891 |
|
- |
|
| Skynner Michael |
CHIEF TECHNOLOGY OFFICER |
• – – |
2024-04-03 |
4 |
S |
$23.81 |
$22,739 |
D/D |
(955) |
94,884 |
|
- |
|
| Keen Nicholas |
CHIEF SCIENTIFIC OFFICER |
• – – |
2024-04-03 |
4 |
S |
$23.81 |
$18,810 |
D/D |
(790) |
62,803 |
|
- |
|
| Milnes Alistair |
CHIEF OPERATING OFFICER |
• – – |
2024-04-03 |
4 |
S |
$23.81 |
$22,739 |
D/D |
(955) |
72,241 |
|
- |
|
| Thompson Travis Alvin |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-04-03 |
4 |
S |
$23.81 |
$3,619 |
D/D |
(152) |
23,223 |
|
- |
|
| Crockett Nigel |
CHIEF BUSINESS OFFICER |
• – – |
2024-04-03 |
4 |
S |
$23.81 |
$22,739 |
D/D |
(955) |
47,761 |
|
- |
|
| Lee Kevin |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-04-03 |
4 |
S |
$23.81 |
$75,192 |
D/D |
(3,158) |
387,270 |
|
- |
|
| Hannay Michael Charles Ferguson |
CHIEF PROD & SUPPLY CHAIN OFF |
• – – |
2024-03-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
23,148 |
|
- |
|
| Sands Stephen H. |
|
– • – |
2024-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
12,000 |
|
- |
|
| Arroyo Santiago |
CHIEF DEVELOPMENT OFFICER |
• – – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
21,660 |
39,000 |
|
- |
|
| Milnes Alistair |
Chief Operating Officer |
• – – |
2024-01-03 |
4 |
S |
$17.50 |
$46,253 |
D/D |
(2,643) |
73,196 |
|
- |
|
| Crockett Nigel |
Chief Business Officer |
• – – |
2024-01-03 |
4 |
S |
$17.50 |
$46,253 |
D/D |
(2,643) |
48,716 |
|
- |
|
| Lee Kevin |
Chief Executive Officer |
• • – |
2024-01-03 |
4 |
S |
$17.50 |
$152,303 |
D/D |
(8,703) |
390,428 |
|
- |
|
| Keen Nicholas |
Chief Scientific Officer |
• – – |
2024-01-03 |
4 |
S |
$17.50 |
$46,200 |
D/D |
(2,640) |
63,593 |
|
- |
|
| Skynner Michael |
Chief Technology Officer |
• – – |
2024-01-03 |
4 |
S |
$17.50 |
$46,253 |
D/D |
(2,643) |
95,839 |
|
- |
|
| Thompson Travis Alvin |
Chief Accounting Officer |
• – – |
2024-01-03 |
4 |
S |
$17.50 |
$10,570 |
D/D |
(604) |
23,375 |
|
- |
|
| Guiterrez-Ramos Jose Carlos |
Director |
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
16,750 |
|
- |
|
| Jordan Veronica Gh |
Director |
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
16,750 |
|
- |
|
| Milnes Alistair |
Chief Operating Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
39,000 |
75,839 |
|
- |
|
| Bourque Janice |
Director |
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
16,750 |
|
- |
|
| Crockett Nigel |
Chief Business Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
51,359 |
|
- |
|
| Lee Kevin |
Chief Executive Officer |
• • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
77,000 |
399,131 |
|
- |
|
| Legault Pierre |
Director |
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
33,500 |
|
- |
|
226 Records found
|
|
Page 1 of 10 |
|
|
